Filter by Industry
Filter by Topic
How drugmakers can prep for Medicare price talks under the IRA
Discover how CMS is driving Medicare drug price negotiation. Learn about the data needed from drug manufacturers to navigate price discussions under…
Life sciences marketing tips
Discover how to successfully market within the life science industry. Explore life sciences marketing strategies, including branding and market…
Sharing real-world wins at HMPS24: How Henry Ford Health improved provider outreach
Discover how Definitive Healthcare helped Henry Ford Health improve provider outreach with an alternative method to volume-based provider targeting.
Leveraging NPI target lists for strategic advertisement placements in pharmaceutical marketing
Discover how a National Provider Identifier (NPI) target list can help pharmaceutical companies deliver impactful messages to HCPs.
The pivotal role of healthcare IDNs and ACOs in purchasing & population health
Discover how healthcare IDNs play a crucial role in both purchasing and population health management. Explore the advantages of joining an IDN vs an…
Find the biopharma experts you’ve been looking for
Discover and connect with the biopharmaceutical experts you’ve been searching for. Find clinical experts in the pharmaceutical industry to collaborate…
How to find clinical leadership with Monocl ExpertInsight
Monocl’s global dataset allows users to analyze the US healthcare system, regardless of diagnosis or procedure, to gain valuable insights into…
What is death by misadventure?
Discover the meaning behind death by misadventure in medical contexts. Understand the implications of accidental and medical error related deaths in…
Personalizing cancer care with precision medicine
Discover how personalizing cancer care is the future of healthcare. Learn why using precision oncology will better diagnose and personalize cancer…
Engaging oncologists in a changing landscape
Navigate the changing oncology market by engaging oncology DOLs. Learn how to adapt to the changing communication preferences of today’s oncologists.